145 related articles for article (PubMed ID: 34039102)
21. Estimating the Cost-Effectiveness of Lung Cancer Screening with Low-Dose Computed Tomography for High-Risk Smokers in Australia.
Wade S; Weber M; Caruana M; Kang YJ; Marshall H; Manser R; Vinod S; Rankin N; Fong K; Canfell K
J Thorac Oncol; 2018 Aug; 13(8):1094-1105. PubMed ID: 29689434
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness of volume computed tomography in lung cancer screening: a cohort simulation based on Nelson study outcomes.
Pan X; Dvortsin E; Baldwin DR; Groen HJM; Ramaker D; Ryan J; Berge HT; Velikanova R; Oudkerk M; Postma MJ
J Med Econ; 2024; 27(1):27-38. PubMed ID: 38050691
[TBL] [Abstract][Full Text] [Related]
23. Biennial lung cancer screening in Canada with smoking cessation-outcomes and cost-effectiveness.
Goffin JR; Flanagan WM; Miller AB; Fitzgerald NR; Memon S; Wolfson MC; Evans WK
Lung Cancer; 2016 Nov; 101():98-103. PubMed ID: 27794416
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness of baseline low-dose computed tomography screening for lung cancer: the Israeli experience.
Shmueli A; Fraifeld S; Peretz T; Gutfeld O; Gips M; Sosna J; Shaham D
Value Health; 2013; 16(6):922-31. PubMed ID: 24041342
[TBL] [Abstract][Full Text] [Related]
25. Cost-Effectiveness of Lung Cancer Screening Using Low-Dose Computed Tomography Based on Start Age and Interval in China: Modeling Study.
Zhao Z; Du L; Li Y; Wang L; Wang Y; Yang Y; Dong H
JMIR Public Health Surveill; 2022 Jul; 8(7):e36425. PubMed ID: 35793127
[TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness of Lung Cancer Screening in Canada.
Goffin JR; Flanagan WM; Miller AB; Fitzgerald NR; Memon S; Wolfson MC; Evans WK
JAMA Oncol; 2015 Sep; 1(6):807-13. PubMed ID: 26226181
[TBL] [Abstract][Full Text] [Related]
27. Cost-Effectiveness Analyses of Lung Cancer Screening Strategies Using Low-Dose Computed Tomography: a Systematic Review.
Raymakers AJN; Mayo J; Lam S; FitzGerald JM; Whitehurst DGT; Lynd LD
Appl Health Econ Health Policy; 2016 Aug; 14(4):409-418. PubMed ID: 26873091
[TBL] [Abstract][Full Text] [Related]
28. The cost-effectiveness of the Manchester 'lung health checks', a community-based lung cancer low-dose CT screening pilot.
Hinde S; Crilly T; Balata H; Bartlett R; Crilly J; Barber P; Threlfall A; Tonge J; Booton R; Crosbie PA
Lung Cancer; 2018 Dec; 126():119-124. PubMed ID: 30527175
[TBL] [Abstract][Full Text] [Related]
29. Shall We Screen Lung Cancer With Low-Dose Computed Tomography? Cost-Effectiveness in Hungary.
Nagy B; Szilberhorn L; Győrbíró DM; Moizs M; Bajzik G; Kerpel-Fronius A; Vokó Z
Value Health Reg Issues; 2023 Mar; 34():55-64. PubMed ID: 36502786
[TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness analysis of a lung cancer screening programme in Spain.
Gómez-Carballo N; Fernández-Soberón S; Rejas-Gutiérrez J
Eur J Cancer Prev; 2022 May; 31(3):235-244. PubMed ID: 34406177
[TBL] [Abstract][Full Text] [Related]
31. Applying utility values in cost-effectiveness analyses of lung cancer screening: A review of methods.
Ngo PJ; Cressman S; Behar-Harpaz S; Karikios DJ; Canfell K; Weber MF
Lung Cancer; 2022 Apr; 166():122-131. PubMed ID: 35276628
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness of implementing computed tomography screening for lung cancer in Taiwan.
Yang SC; Lai WW; Lin CC; Su WC; Ku LJ; Hwang JS; Wang JD
Lung Cancer; 2017 Jun; 108():183-191. PubMed ID: 28625633
[TBL] [Abstract][Full Text] [Related]
33. Cost-Effectiveness of Treatment Thresholds for Subsolid Pulmonary Nodules in CT Lung Cancer Screening.
Hammer MM; Eckel AL; Palazzo LL; Kong CY
Radiology; 2021 Sep; 300(3):586-593. PubMed ID: 34128723
[TBL] [Abstract][Full Text] [Related]
34. Clinical impact and cost-effectiveness of integrating smoking cessation into lung cancer screening: a microsimulation model.
Evans WK; Gauvreau CL; Flanagan WM; Memon S; Yong JHE; Goffin JR; Fitzgerald NR; Wolfson M; Miller AB
CMAJ Open; 2020; 8(3):E585-E592. PubMed ID: 32963023
[TBL] [Abstract][Full Text] [Related]
35. Cost-Effectiveness Analysis of Risk Factor-Based Lung Cancer Screening Program by Low-Dose Computer Tomography in Current Smokers in China.
Zhang T; Chen X; Li C; Wen X; Lin T; Huang J; He J; Zhong N; Jiang J; Liang W
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760416
[TBL] [Abstract][Full Text] [Related]
36. Favorable incremental cost-effectiveness ratio for lung cancer screening in Italy.
Veronesi G; Navone N; Novellis P; Dieci E; Toschi L; Velutti L; Solinas M; Vanni E; Alloisio M; Ghislandi S
Lung Cancer; 2020 May; 143():73-79. PubMed ID: 32234647
[TBL] [Abstract][Full Text] [Related]
37. Can we increase efficiency of CT lung cancer screening by combining with CVD and COPD screening? Results of an early economic evaluation.
Behr CM; Koffijberg H; Degeling K; Vliegenthart R; IJzerman MJ
Eur Radiol; 2022 May; 32(5):3067-3075. PubMed ID: 34973103
[TBL] [Abstract][Full Text] [Related]
38. Lung cancer screening with low-dose computed tomography: costs, national expenditures, and cost-effectiveness.
Goulart BH; Bensink ME; Mummy DG; Ramsey SD
J Natl Compr Canc Netw; 2012 Feb; 10(2):267-75. PubMed ID: 22308519
[TBL] [Abstract][Full Text] [Related]
39. Health Economic Evaluation of Lung Cancer Screening Using a Diagnostic Blood Test: The Early Detection of Cancer of the Lung Scotland (ECLS).
Robles-Zurita JA; McMeekin N; Sullivan F; Mair FS; Briggs A
Curr Oncol; 2024 Jun; 31(6):3546-3562. PubMed ID: 38920744
[TBL] [Abstract][Full Text] [Related]
40. Moving beyond the national lung screening trial: discussing strategies for implementation of lung cancer screening programs.
Goulart BH; Ramsey SD
Oncologist; 2013; 18(8):941-6. PubMed ID: 23873718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
